The duty of care: a genetic balancing act?
Genetic testing is becoming a standard part of UK healthcare, with plans to expand its use. But who does this information belong to, and who decides who it is shared with?
Developing a view on Brexit
Sarion Bowers, Policy Lead at the Sanger Institute, reflects on how Brexit will affect science.
Human genome editing – the issues explored
Hayley Clissold from the Sanger Institute's policy team team explores the issues surrounding gene editing and human embryos
Scientific Evidence in Policy Making
Evidence is a vital part of policy-making - but it's by no means the only part. We look at how scientists can get involved and make a difference.
Claims of genome edited babies shock the world
Our Policy Lead, Sarion Bowers, explores the extraordinary claims that the world’s first genome edited babies have been born.
Human Embryo Editing: science fiction or science fact?
Anna Middleton, Head of the Society and Ethics research group at Wellcome Genome Campus Connecting Science, reports on Prof He Jiankiu's unverified announcement of gene editing the first human embryos that have been born
Science as a human right
The idea that we should benefit from scientific advancement is something we may never have thought of as human right, yet the Universal Declaration of Human Rights firmly makes the case that it is everyone's right, regardless of education, wealth or background, explains Sarion Bowers
A new deal on data – articulating the contract between science and people
Now is the time for scientists to strike a deal everyone that benefits society as well as research, argue Anna Middleton, Vivienne Parry and Julian Borra
Editing embryos – Could you? Would you? Should you? Views from Genetic Counsellors
03.08.17 This week the American Society of Human Genetics issued a policy on the application of germline editing – the ability to alter the genetic makeup of early stage embryos. Anna Middleton, one of the contributors to the statement, explains the policy's position
